Zoli Matteo, Sollini Giacomo, Rustici Arianna, Guaraldi Federica, Asioli Sofia, Altavilla Maria Vittoria, Orsatti Agnese, Faustini-Fustini Marco, Pasquini Ernesto, Mazzatenta Diego
IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma Neurochirurgia Ipofisi- Pituitary Unit, Bologna, Italy; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
ENT Unit, Azienda USL di Bologna, Bellaria Hospital, Bologna, Italy.
World Neurosurg. 2023 Sep;177:e239-e253. doi: 10.1016/j.wneu.2023.06.026. Epub 2023 Jun 16.
Transorbital neuroendoscopic surgery (TONES) comprises a group of approaches with indications expanding from orbital tumors to more complex skull base lesions. We analyzed the role of the endoscopic transorbital approach (eTOA) for spheno-orbital tumors, reporting the results of our clinical series and of a systematic review of the literature.
All patients operated on from 2016 to 2022 at our institution for a spheno-orbital tumor through an eTOA were included in a clinical series, and a systematic review of the literature was performed.
Our series consisted of 22 patients (16 females, mean age 57 ± 13 years). Gross tumor removal was achieved in 8 patients (36.4%) after the eTOA and in 11 (50.0%) after a multistaged strategy combining the eTOA with the endoscopic endonasal approach. Complications included 1 chronic subdural hematoma and 1 permanent extrinsic ocular muscle deficit. Patients were discharged after 2.4 ± 1.3 days. The most common histotype was meningioma (86.4%). Proptosis improved in all cases, visual deficit in 66.6%, and diplopia in 76.9%. These results were confirmed by the review of the 127 cases reported in the literature.
Despite its recent introduction, a significant number of spheno-orbital lesions treated with an eTOA are being reported. Its main advantages are favorable patient outcome and optimal cosmetic results, with minimal morbidity and quick recovery. This approach can be combined with other surgical routes or adjuvant therapies for complex tumors. However, it is a technically demanding procedure, requiring specific skills in endoscopic surgery, that should be reserved to dedicated centers.
经眶神经内镜手术(TONES)包括一组手术方法,其适应证已从眼眶肿瘤扩展到更复杂的颅底病变。我们分析了内镜经眶入路(eTOA)治疗蝶眶肿瘤的作用,报告了我们临床系列研究的结果以及对文献的系统综述。
将2016年至2022年在我们机构通过eTOA手术治疗蝶眶肿瘤的所有患者纳入临床系列研究,并对文献进行系统综述。
我们的系列研究包括22例患者(16例女性,平均年龄57±13岁)。eTOA术后8例患者(36.4%)实现了肿瘤全切,eTOA与内镜鼻内入路相结合的多阶段策略术后11例患者(50.0%)实现了肿瘤全切。并发症包括1例慢性硬膜下血肿和1例永久性眼外肌功能障碍。患者在2.4±1.3天后出院。最常见的组织学类型是脑膜瘤(86.4%)。所有病例的眼球突出均有改善,66.6%的患者视力缺陷得到改善,76.9%的患者复视得到改善。文献综述报道的127例病例证实了这些结果。
尽管eTOA是最近才引入的,但已有大量关于其治疗蝶眶病变的报道。其主要优点是患者预后良好、美容效果最佳,发病率最低且恢复快。对于复杂肿瘤,这种方法可与其他手术途径或辅助治疗相结合。然而,这是一种技术要求很高的手术,需要内镜手术的特定技能,应仅在专业中心开展。